Associated Papers
Preliminary analysis of lifestyle and genetic factors for hyperuricemia and gout prevalence in the Yunnan Miao population of China.
Li Q et al.
Frontiers in Genetics, 2026
Association of Functional Genetic Variations in Uric Acid Transporters with the Risk of Idiopathic Male Infertility: A Genetic Association Study and Bioinformatic Analysis.
Karimian M et al.
Biochemical Genetics, 2025
Clinical and Genetic Analysis of a Female Patient With Adolescent-Onset Gout.
Li X et al.
The Journal of Rheumatology, 2025
Structural basis of urate transport by glucose transporter 9.
Matsushita D et al.
Cell Reports, 2025
The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.
Wang LY et al.
Innovation (cambridge (mass.)), 2025
APF2: an improved ensemble method for pharmacogenomic variant effect prediction.
Zhou Y et al.
The Pharmacogenomics Journal, 2024
Genomic characteristics and immune landscape of super multiple primary lung cancer.
Yang Z et al.
Ebiomedicine, 2024
Novel NARS2 variants in a patient with early-onset status epilepticus: case study and literature review.
Yang N et al.
Bmc Pediatrics, 2024
Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout.
Vávra J et al.
Disease Markers, 2024
Renal Hypouricemia 1: Rare Disorder as Common Disease in Eastern Slovakia Roma Population.
Stiburkova B et al.
Biomedicines, 2021
A synergetic effect of BARD1 mutations on tumorigenesis.
Li W et al.
Nature Communications, 2021
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia.
Fontana D et al.
Hemasphere, 2020
Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout.
Pavelcova K et al.
Journal of Clinical Medicine, 2020
Donor-derived hypouricemia in irrelevant recipients caused by kidney transplantation.
Teng L et al.
Annals of Translational Medicine, 2020
Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects.
Zhou Z et al.
Molecular Genetics & Genomic Medicine, 2019
An optimized prediction framework to assess the functional impact of pharmacogenetic variants.
Zhou Y et al.
The Pharmacogenomics Journal, 2019
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
Stiburkova B et al.
Arthritis Research & Therapy, 2019
Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.
Yasukochi Y et al.
Molecular Genetics and Genomics : Mgg, 2018
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
Tang X et al.
Nucleic Acids Research, 2014
Metabolic syndrome, alcohol consumption and genetic factors are associated with serum uric acid concentration.
Stibůrková B et al.
Plos One, 2014
Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.
Hurba O et al.
Plos One, 2014
Acute kidney injury in two children caused by renal hypouricaemia type 2.
Stiburkova B et al.
Pediatric Nephrology (berlin, Germany), 2012
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.
Vitart V et al.
Nature Genetics, 2008